The presentation discusses the challenges of identifying high-voltage component failures in implantable cardioverter-defibrillators (ICDs), which can often remain undetected and may lead to sudden cardiac events. It reviews methods for detecting potential failures, emphasizes the limitations of current testing practices, and highlights the need for improved post-mortem interrogations and protocols for assessing ICD leads. Examples of notable high-voltage failures, including those associated with specific lead models like Medtronic Fidelis and St. Jude Riata, underline the complexity and seriousness of these issues.